An Overview of Obesity, Cholesterol, and Systemic Inflammation in Preeclampsia
Preeclampsia (PE), an inflammatory state during pregnancy, is a significant cause of maternal and fetal morbidity and mortality. Adverse outcomes associated with PE include hypertension, proteinuria, uterine/placental abnormalities, fetal growth restriction, and pre-term birth. Women with obesity have an increased risk of developing PE likely due to impaired placental development from altered metabolic homeostasis. Inflammatory cytokines from maternal adipose tissue and circulating cholesterol have been linked to systemic inflammation, hypertension, and other adverse outcomes associated with PE. This review will summarize the current knowledge on the role of nutrients, obesity, and cholesterol signaling in PE with an emphasis on findings from preclinical models.
Publication Source (Journal or Book title)
Alston, M. C., Redman, L. M., & Sones, J. L. (2022). An Overview of Obesity, Cholesterol, and Systemic Inflammation in Preeclampsia. Nutrients, 14 (10) https://doi.org/10.3390/nu14102087